e-therapeutics plc
ETXPF
$0.13
-$0.01-7.14%
OTC PK
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.93M | -13.11M | -12.22M | -11.02M | -10.12M |
| Total Depreciation and Amortization | 589.90K | 598.90K | 603.80K | 580.40K | 574.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.25M | -1.31M | -1.38M | -881.40K | -438.20K |
| Change in Net Operating Assets | 1.01M | 797.00K | 577.30K | 349.60K | 86.30K |
| Cash from Operations | -13.59M | -13.03M | -12.42M | -10.97M | -9.89M |
| Capital Expenditure | -309.10K | -166.90K | -26.40K | -54.40K | -85.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 597.70K | 670.10K | 734.80K | 9.77M | 19.54M |
| Cash from Investing | 288.60K | 503.30K | 708.50K | 9.72M | 19.46M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -396.00K | -498.50K | -601.00K | -496.00K | -391.00K |
| Issuance of Common Stock | 37.00K | 6.74M | 13.45M | 13.44M | 13.44M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -448.00K | 7.52M | 15.14M | 15.27M | 15.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.75M | -5.00M | 3.43M | 14.02M | 24.95M |